Evidence map›Paper›PMID 26604306›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

TRPC6 channel translocation into phagosomal membrane augments phagosomal function.

Vladimir Riazanski, Aida G Gabdoulkhakova, Lin S Boynton, Raphael R Eguchi, Ludmila V Deriy, D Kyle Hogarth, Nadège Loaëc, Nassima Oumata, Hervé Galons, Mary E Brown and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. A Putative Role for TRPC6 in Immune-Mediated Kidney Injury.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Review
  13. Impact ofInternational journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Roscovitine WorsensAmerican journal of respiratory cell and molecular biology · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Vladimir RiazanskiDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Aida G GabdoulkhakovaDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Lin S BoyntonDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Raphael R EguchiDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Ludmila V DeriyDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
D Kyle HogarthDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Nadège LoaëcDepartment of Research and Development, ManRos Therapeutics, Hôtel de Recherche, Centre de Perharidy, 29680 Roscoff, France;
Nassima OumataDepartment of Research and Development, ManRos Therapeutics, Hôtel de Recherche, Centre de Perharidy, 29680 Roscoff, France;
Hervé GalonsUnité de Technologies Chimiques et Biologiques pour la Santé, Université Paris Descartes UMR-S 1022 INSERM 75270, Paris Cedex 06, France;
Mary E BrownDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Pavel ShevchenkoDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Alexander J GallanDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Sang Gune YooDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Anjaparavanda P NarenDepartment of Pediatrics, Division of Pulmonary Medicine and Gastroenterology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229;
Mitchel L VillerealDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Daniel W BeachamMolecular Probes, Thermo Scientific, Eugene, OR 97402;
Vytautas P BindokasDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637;
Lutz BirnbaumerLaboratory of Neurobiology, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709 Birnbau1@gmail.com nelson@uchicago.edu.
Laurent MeijerDepartment of Research and Development, ManRos Therapeutics, Hôtel de Recherche, Centre de Perharidy, 29680 Roscoff, France;
Deborah J NelsonDepartment of Pharmacological and Physiological Sciences and Department of Medicine, University of Chicago, Chicago, IL 60637; Birnbau1@gmail.com nelson@uchicago.edu.
University of Chicago · USManRos Therapeutics (France) · FRCincinnati Children's Hospital Medical Center · USNational Institute of Environmental Health Sciences · USUniversité Paris Cité · FR

Funding

Tissue Culture Biomechanical CoreP01HL058064 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAL, RATNESHWAR · 1998 to 2012
$27.8M
Therapeutic Potential of FTY720 Analogues in Lung InjuryP01HL098050 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2011 to 2015
$10.9M
Inhibition of an apical cAMP transporter (MRP4) in the gut induces diarrheaR01DK080834 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI Anjaparavanda P Naren · 2009 to 2026
$6.8M
Phagosomal Ion Channels as Therapeutic TargetsR01HL125076 · NHLBI · UNIVERSITY OF CHICAGO · PI NELSON, DEBORAH J. · 2015 to 2022
$5.0M
ROLE OF ION CHANNELS IN MONONUCLEAR PHAGOCYTE ACTIVATIONR01GM036823 · NIGMS · UNIVERSITY OF CHICAGO · PI NELSON, DEBORAH J. · 1986 to 2012
$3.2M
Regulation of Asthmatic Inflammation by Non-Muscle MLCKR01HL091889 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GARCIA, JOE G. N., WANG, TING · 2008 to 2018
$3.2M
LPA2 receptor-containing complexes in regulating secretory diarrheaR01DK093045 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI NAREN, ANJAPARAVANDA P · 2011 to 2019
$3.0M
Transmembrane Signaling Mechanisms Involving TRP ChannelsZ01ES101684 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI BIRNBAUMER, LUTZ · 2003 to 2008
$2.1M
Cortactin in Regulation of Pulmonary Vascular PermeabilityR01HL088144 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEK, STEVEN M · 2007 to 2011
$1.9M
Chloride Channel Involvement in DiabetesR01DK080364 · NIDDK · UNIVERSITY OF CHICAGO · PI NELSON, DEBORAH J. · 2009 to 2012
$1.6M
Identifying molecules that augment mutant CFTR activityR01DK058545 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI NAREN, ANJAPARAVANDA P · 2002 to 2006
$1.1M
Intramural NIH HHS Z01 ES101684NHLBI NIH HHS P01 HL058064NHLBI NIH HHS P01 HL098050NHLBI NIH HHS R01 HL125076NIDDK NIH HHS R01 DK058545NIDDK NIH HHS R01 DK080364NIDDK NIH HHS R01 DK080834NIDDK NIH HHS R01 DK093045NIEHS NIH HHS Z01-ES-101684NIGMS NIH HHS R01 GM036823NIGMS NIH HHS R01 GM36823
6 · The paper itself

Abstract

Defects in the innate immune system in the lung with attendant bacterial infections contribute to lung tissue damage, respiratory insufficiency, and ultimately death in the pathogenesis of cystic fibrosis (CF). Professional phagocytes, including alveolar macrophages (AMs), have specialized pathways that ensure efficient killing of pathogens in phagosomes. Phagosomal acidification facilitates the optimal functioning of degradative enzymes, ultimately contributing to bacterial killing. Generation of low organellar pH is primarily driven by the V-ATPases, proton pumps that use cytoplasmic ATP to load H(+) into the organelle. Critical to phagosomal acidification are various channels derived from the plasma membrane, including the anion channel cystic fibrosis transmembrane conductance regulator, which shunt the transmembrane potential generated by movement of protons. Here we show that the transient receptor potential canonical-6 (TRPC6) calcium-permeable channel in the AM also functions to shunt the transmembrane potential generated by proton pumping and is capable of restoring microbicidal function to compromised AMs in CF and enhancement of function in non-CF cells. TRPC6 channel activity is enhanced via translocation to the cell surface (and then ultimately to the phagosome during phagocytosis) in response to G-protein signaling activated by the small molecule (R)-roscovitine and its derivatives. These data show that enhancing vesicular insertion of the TRPC6 channel to the plasma membrane may represent a general mechanism for restoring phagosome activity in conditions, where it is lost or impaired.

Indexed as

AcidsAnimalsCalciumCalcium SignalingCell LineCell MembraneCystic Fibrosis Transmembrane Conductance RegulatorDiglyceridesExocytosisFluorescent Antibody TechniqueHumansIntracellular MembranesIon Channel GatingMacrophages, AlveolarMiceMicrobial ViabilityAcidsCalciumCystic Fibrosis Transmembrane Conductance RegulatorDiglyceridesPertussis ToxinPurinesReceptors, G-Protein-CoupledRoscovitineSmall Molecule LibrariesTRPC6 Cation ChannelTRPC6 protein, humanTrpc6 protein, mouseTRPC Cation Channelsalveolar macrophagecystic fibrosisphagosomeroscovitineTRPC6

Identifiers

PMID26604306
PMCPMC4664321
OpenAlexW2256283585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.